Pfizer (PFE) CEO Buys $1 Million of Company Stock
The pharma giant’s earnings beat Wall Street forecasts.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 109,067,291 | $2,626,340,379 | +4% | 0.78% |
| 2. | 19,082,700 | $459,511,416 | +59% | 0.05% | |
| 3. | AQR Capital Management Cliff Asness | 18,557,891 | $445,018,217 | +57% | 0.16% |
| 4. | Unisphere Establishment Hani Lazkani (Ceo) | 14,650,000 | $352,772,000 | 3% | |
| 5. | 7,435,700 | $179,051,656 | -18% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.34 | 38,000 | $1,000,920.00 | 429,173 | 2026-08-12 | Filing | |
| $25.46 | 39,231 | $998,821.26 | 66,938 | 2026-08-05 | Filing | |
| $25.52 | 37,632 | $960,368.64 | 37,632 | 2026-08-05 | Filing | |
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.40 | 3,278 | $83,261.20 | 28,611 | 2026-08-05 | Filing | |
| $25.70 | 2,000 | $51,400.00 | 31,397 | 2026-06-09 | Filing | |
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 529,670,433 | $12,754,464,030 | 0.19% | |
| 2. | 372,149,852 | $8,961,368,437 | 0.19% | |
| 3. | 307,090,897 | $7,394,748,800 | 0.22% | |
| 4. | 135,275,782 | $3,245,359,604 | 0.17% | |
| 5. | 119,235,030 | $2,871,179,523 | 0.13% |
News See All
Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes
Shares in biotech Valneva ($VALN) soared over 20% in early trading today after it and partner Pfizer ($PFE) as it moved closer to bringing its Lyme...
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings alongside major strategic announcements.
Pfizer’s (PFE) Q2 Earnings Support a Bullish View
I maintain my bullish stance on Pfizer, Inc. ($PFE) following its Q2 earnings print. While short-term volatility remains likely, I believe the comp...
Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat
Pfizer’s ($PFE) shares edged lower during Tuesday’s pre-market session after the U.S. pharma giant raised its full-year 2026 sales outlook but stil...
Options Volatility and Implied Earnings Moves Today, August 04, 2026
Today, several major companies are expected to report earnings: Advanced Micro Devices (AMD), Caterpillar (CAT), Energy Transfer (ET), Gilead Scien...
These Are the Stocks Reporting Earnings Today – August 4, 2026
Here’s a look at today’s most important earnings reports from major publicly traded companies. Investors will be watching closely for revenue and p...
Options Volatility and Implied Earnings Moves This Week, August 03 – August 06, 2026
This week, several major companies will be reporting earnings. Among them are Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Walt Disn...
Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma
Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry.
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data.
Hedge Fund Resource Center